CoChat
Sign Up
Cited by 342Pharmacology and Obesity TreatmentBariatric Surgery and OutcomesObesity, Physical Activity, Diet

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

The FDA's Assessment of Two Drugs for Chronic Weight Management

Colman, Eric, Golden, Julie, Roberts, Mary, Egan, Amy, Weaver, Joyce, Rosebraugh, Curtis·2012·New England Journal of Medicine
DOI 10.1056/nejmp1211277
Open this paper in CoChat — free account

Abstract

After weighing the risks and benefits, the FDA recently approved two new drugs as adjuncts to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adults with at least one weight-related coexisting condition.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmp1211277

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 13 references

Cited by

Sorted by citations

Items 201–300 of 341

Related

See all

Metadata

Authors
Colman, E., Golden, J., Roberts, M., Egan, A., Weaver, J., & Rosebraugh, C.
Affiliations
United States Food and Drug Administration (US)
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2012-10-25
Volume
367
Issue
17
Pages
1577-1579
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmp1211277
OpenAlex
W2331430051
Cited by
342
References
13
Citations by year
2026: 4 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 14 · 2020: 162 · 2019: 11 · 2018: 7 · 2017: 17 · 2016: 18 · 2015: 22 · 2014: 24 · 2013: 42 · 2012: 3
FWCI
21.58
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
chronic weight management, obesity, overweight adults, FDA drug approval, anti-obesity drugs, adjunctive therapy, hypocaloric diet, physical activity, comorbidities, risk-benefit assessment
MeSH terms
Abnormalities, Drug-Induced, Topiramate, Benzazepines, Delayed-Action Preparations, Drug Combinations, Female, Fructose, Humans, Obesity, Phentermine, Pregnancy, United States, United States Food and Drug Administration, Weight Loss, Drug Approval, Serotonin Receptor Agonists, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review